Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation and continuous renal replacement therapy.

Jamshid Amanzadeh1, Robert F Reilly

  • 1Section of Nephrology, Veterans Affairs North Texas Health Care System and Department of Medicine, University of Texas Southwestern Medical Center at Dallas, Texas 75390, USA. Jamshid.Amanzadeh@med.va.gov

Seminars in Dialysis
|August 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Warfarin in nonvalvular atrial fibrillation-Time for a change?

Seminars in dialysis·2019
Same author

Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2018
Same author

Hungry bone syndrome.

Current opinion in nephrology and hypertension·2017
Same author

We Use Too Much Vitamin D in Hemodialysis Patients.

Seminars in dialysis·2016
Same author

Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current Knowledge and Future Directions.

Seminars in dialysis·2016
Same author

Medical and surgical care during the American Civil War, 1861-1865.

Proceedings (Baylor University. Medical Center)·2016
Same journal

Intracardiac Vascular Access for Hemodialysis Despite Associated Ascending Aortic Aneurysm.

Seminars in dialysis·2026
Same journal

Measures of Equivalent Hemodialysis Urea Clearance and Their Proposed Utility for Monitoring Adequacy.

Seminars in dialysis·2026
Same journal

Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

Seminars in dialysis·2026
Same journal

Severe Hematoma Following Initial Arteriovenous Fistula Puncture in a Hemodialysis Patient, Emphasizing Thoracic Outlet Syndrome: A Case Report.

Seminars in dialysis·2026
Same journal

Phosphate Kinetic Modeling in Patients Treated With Hemodialysis or Hemodiafiltration: A Prospective, Multicenter, Cross-Sectional Study.

Seminars in dialysis·2026
Same journal

Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients.

Seminars in dialysis·2026
See all related articles

Continuous renal replacement therapy (CRRT) requires anticoagulation for critically ill patients with acute renal failure. Alternative anticoagulation methods beyond heparin are explored to balance bleeding risks and circuit clotting for effective dialysis.

Area of Science:

  • Nephrology
  • Intensive Care Medicine
  • Critical Care

Background:

  • Acute renal failure (ARF) is common in intensive care units (ICUs), often necessitating dialysis.
  • Hemodynamic instability affects the majority of ICU patients requiring dialysis.
  • Continuous renal replacement therapy (CRRT) is a preferred dialysis method for unstable patients.

Purpose of the Study:

  • To review anticoagulation strategies for CRRT in critically ill patients.
  • To highlight the challenges of anticoagulation in CRRT.
  • To discuss alternatives to heparin for CRRT anticoagulation.

Main Methods:

  • Review of literature on CRRT anticoagulation.
  • Discussion of various anticoagulation agents and protocols.

Related Experiment Videos

  • Analysis of risks and benefits associated with different methods.

    • Main Results:

    • Effective anticoagulation is crucial for CRRT circuit patency and treatment efficacy.
    • Heparins, while common, carry risks of bleeding and heparin-induced thrombocytopenia.
    • Several alternative anticoagulation methods exist, including citrate, regional heparin/protamine, r-hirudin, prostacyclin, and nafamostat.

    Conclusions:

    • Balancing anticoagulation efficacy and bleeding risk is essential in CRRT.
    • Alternative anticoagulation protocols offer options for patients at risk from heparin.
    • Further research into optimal anticoagulation strategies for CRRT is warranted.